# EDGAR Filing Document

**Accession Number:** 0001849296
**File Stem:** 0000000000-26-001302
**Filing Date:** 2026-2
**Character Count:** 2110
**Document Hash:** 0e8e1339c96ecf107355b2bd84222e45
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-001302.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0000000000-26-001302

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260206

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** OKYO Pharma Ltd
- **CENTRAL INDEX KEY:** 0001849296
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-293145

**BUSINESS ADDRESS:**
- **STREET 1:** 55 PARK LANE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1K 1NA
- **BUSINESS PHONE:** 44 (0) 207 495 2379

**MAIL ADDRESS:**
- **STREET 1:** 55 PARK LANE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W1K 1NA
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001493152-26-004784

## Text-Extract

```

                                                           February 6, 2026

Robert J. Dempsey
Chief Executive Officer and Director
OKYO Pharma Limited
Martello Court
Admiral Park
St. Peter Port
Guernsey GY1 3HB

       Re: OKYO Pharma Limited
           Registration Statement on Form F-3
           Filed February 2, 2026
           File No. 333-293145
Dear Robert J. Dempsey:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Daniel Crawford at 202-551-7767 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Anna Tomczyk, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._